Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin

Autophagy plays critical roles in tumorigenesis, while the effects of Autophagy on chemoresistance of Cancer cells had great disparity. This study aims to explore the impacts of Autophagy on the sensitivity and resistance of gastric Cancer cells to cisplatin (DDP). We firstly demonstrated that there was stronger Autophagy activity in gastric Cancer SGC-7901 cells than that in DDP-resisting SGC-7901/DDP cells. Then, we discovered that inhibiting Autophagy by chloroquine (CQ) significantly enhanced the proliferation-inhibiting and apoptosis-inducing effects of DDP to SGC-7901 and SGC-7901/DDP cells. Moreover, CQ could partially reverse the resistance of SGC-7901/DDP cells to DDP in a concentration-dependent manner. However, the Autophagy inducer everolimus (RAD001) had no obvious effects on the sensitivity of gastric cells to DDP. Mechanistically, we demonstrated that CQ might enhance the sensitivity of SGC-7901cells and improve the resistance of SGC-7901/DDP cells to DDP through inhibiting the mTORC1 pathway, especially to SGC-7901/DDP cells. Additionally, we found interfering Beclin-1 using Beclin-1 shRNA also enhanced the proliferation-inhibiting and apoptosis-inducing effects of DDP on gastric Cancer cells by inhibiting phosphorylation of Akt. Our study shows that inhibiting Autophagy could improve the chemoresistance and enhanced sensitivity of gastric Cancer cells to DDP and provide a rationale for the administration of cisplatin combined with CQ for treating patients with gastric Cancer.